{"id":"W4396590874","doi":"10.1158/1538-7445.sabcs23-gs03-03","title":"Abstract GS03-03: Ribociclib (RIB) + nonsteroidal aromatase inhibitor (NSAI) as adjuvant treatment in patients with HR+/HER2− early breast cancer: final invasive disease–free survival (iDFS) analysis from the NATALEE trial","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Aromatase inhibitor; Oncology; Breast cancer; Internal medicine; Nonsteroidal; Cancer; Adjuvant; Aromatase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005794891,0.0005714151,0.0009367748,0.0006135716,0.0002941878,0.0002759955,0.000660979,0.0001584273,0.001607384],"category_scores_gemma":[0.0001502577,0.0003632645,0.0003681357,0.002267846,0.0006933485,0.000489591,0.0002494847,0.00105557,0.0001534434],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002541137,"about_ca_system_score_gemma":0.003404705,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.04005482,"about_ca_topic_score_gemma":0.02088212,"domain_scores_codex":[0.9942168,0.0003729087,0.0006432779,0.001305096,0.002334065,0.00112786],"domain_scores_gemma":[0.9963515,0.0009872742,0.0001440206,0.001401668,0.0004669939,0.0006485668],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2348056,0.001741014,0.6880048,0.0002851366,0.005827406,0.001619962,0.002929842,0.0003946074,0.0006921807,0.00004721367,0.001338609,0.06231363],"study_design_scores_gemma":[0.04650176,0.001288075,0.945945,0.001343773,0.00099638,0.000004760478,0.0005615363,0.00004414473,0.0005994306,0.0002291455,0.002034291,0.0004517511],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9711479,0.00763634,0.000007224437,0.004187076,0.0005577655,0.002695553,0.01358673,0.0001052808,0.00007612428],"genre_scores_gemma":[0.9939587,0.0006344838,0.0000343373,0.0001371725,0.0016048,0.001972072,0.001050826,0.0001217677,0.0004858537],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2579402,"threshold_uncertainty_score":0.9998819,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0456993050106724,"score_gpt":0.3655562562316668,"score_spread":0.3198569512209944,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}